facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
5/2020
vol. 107
 
Share:
Share:
abstract:
Case report

Sweet’s syndrome in a 45-year-old patient

Dorota Kozłowska
1
,
Agnieszka B. Serwin
1
,
Iwona Flisiak
1

  1. Department of Dermatology and Venereology, Medical University of Bialystok, Poland
Dermatol Rev/Przegl Dermatol 2020, 107, 469-475
Online publish date: 2020/12/29
View full text Get citation
 
PlumX metrics:
Introduction
Sweet’s syndrome, also known as acute febrile neutrophilic dermatosis, is a rare neutrophilic dermatosis of sudden onset. The disease may be induced by preceding infectious diseases, coexist with autoimmune diseases, be a revelator of proliferative diseases, and also be provoked by drugs.

Objective
To present a case of a patient with Sweet’s syndrome successfully treated with prednisone and dapsone.

Case report
A forty-five-year-old man was admitted to the Department of Dermatology and Venereology for the differential diagnosis and treatment of skin lesions that had persisted for a month. Sweet’s syndrome was diagnosed on the basis of the clinical presentation and histopathology. All skin lesions resolved after tretment with prednisone and dapsone.

Conclusions
Oral glucocorticosteroids are the first-line therapy, and improvement in the local condition is observed during the first few days of treatment. Because of the possible comorbidities, which include neoplastic diseases, patients with Sweet’s syndrome require thorough work-up and long-term follow-up after treatment.

keywords:

prednisone, neutrophilic dermatoses, Sweet’s syndrome



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.